Epithelial	epithelial	O	O	O	O
sodium	sodium	CHEMICALS	O	OTHERS	I
channel	channel	O	O	O	O
(	(	O	O	O	O
ENaC	enac	O	O	O	O
)	)	O	O	O	O
subunit	subunit	O	O	O	O
mRNA	mrna	O	O	O	O
and	and	O	O	O	O
protein	protein	O	O	O	O
expression	expression	O	O	O	O
in	in	O	O	O	O
rats	rats	O	O	O	O
with	with	O	O	O	O
puromycin	puromycin	O	O	O	O
aminonucleoside-induced	aminonucleoside-induced	O	O	O	O
nephrotic	nephrotic	O	DISEASE	OTHERS	I
syndrome	syndrome	O	DISEASE	OTHERS	I
.	.	O	O	O	O

In	in	O	O	O	O
experimental	experimental	O	O	O	O
nephrotic	nephrotic	O	DISEASE	OTHERS	I
syndrome	syndrome	O	DISEASE	OTHERS	I
,	,	O	O	O	O
urinary	urinary	O	O	O	O
sodium	sodium	CHEMICALS	O	OTHERS	I
excretion	excretion	O	O	O	O
is	is	O	O	O	O
decreased	decreased	O	O	O	O
during	during	O	O	O	O
the	the	O	O	O	O
early	early	O	O	O	O
phase	phase	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
disease	disease	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
molecular	molecular	O	O	O	O
mechanism(s	mechanism(s	O	O	O	O
)	)	O	O	O	O
leading	leading	O	O	O	O
to	to	O	O	O	O
salt	salt	CHEMICALS	O	OTHERS	I
retention	retention	O	O	O	O
has	has	O	O	O	O
not	not	O	O	O	O
been	been	O	O	O	O
completely	completely	O	O	O	O
elucidated	elucidated	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
rate-limiting	rate-limiting	O	O	O	O
constituent	constituent	O	O	O	O
of	of	O	O	O	O
collecting	collecting	O	O	O	O
duct	duct	O	O	O	O
sodium	sodium	CHEMICALS	O	OTHERS	I
transport	transport	O	O	O	O
is	is	O	O	O	O
the	the	O	O	O	O
epithelial	epithelial	O	O	O	O
sodium	sodium	CHEMICALS	O	OTHERS	I
channel	channel	O	O	O	O
(	(	O	O	O	O
ENaC	enac	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

We	we	O	O	O	O
examined	examined	O	O	O	O
the	the	O	O	O	O
abundance	abundance	O	O	O	O
of	of	O	O	O	O
ENaC	enac	O	O	O	O
subunit	subunit	O	O	O	O
mRNAs	mrnas	O	O	O	O
and	and	O	O	O	O
proteins	proteins	O	O	O	O
in	in	O	O	O	O
puromycin	puromycin	CHEMICALS	O	OTHERS	I
aminonucleoside	aminonucleoside	CHEMICALS	O	OTHERS	I
(PAN)-induced	(pan)-induced	O	O	O	O
nephrotic	nephrotic	O	DISEASE	OTHERS	I
syndrome	syndrome	O	DISEASE	OTHERS	I
.	.	O	O	O	O

The	the	O	O	O	O
time	time	O	O	O	O
courses	courses	O	O	O	O
of	of	O	O	O	O
urinary	urinary	O	O	O	O
sodium	sodium	CHEMICALS	O	OTHERS	I
excretion	excretion	O	O	O	O
,	,	O	O	O	O
plasma	plasma	O	O	O	O
aldosterone	aldosterone	CHEMICALS	O	OTHERS	I
concentration	concentration	O	O	O	O
and	and	O	O	O	O
proteinuria	proteinuria	O	DISEASE	OTHERS	I
were	were	O	O	O	O
studied	studied	O	O	O	O
in	in	O	O	O	O
male	male	O	O	O	O
Sprague-Dawley	sprague-dawley	O	O	O	O
rats	rats	O	O	O	O
treated	treated	O	O	O	O
with	with	O	O	O	O
a	a	O	O	O	O
single	single	O	O	O	O
dose	dose	O	O	O	O
of	of	O	O	O	O
either	either	O	O	O	O
PAN	pan	CHEMICALS	O	OTHERS	I
or	or	O	O	O	O
vehicle	vehicle	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
relative	relative	O	O	O	O
amounts	amounts	O	O	O	O
of	of	O	O	O	O
alphaENaC	alphaenac	O	O	O	O
,	,	O	O	O	O
betaENaC	betaenac	O	O	O	O
and	and	O	O	O	O
gammaENaC	gammaenac	O	O	O	O
mRNAs	mrnas	O	O	O	O
were	were	O	O	O	O
determined	determined	O	O	O	O
in	in	O	O	O	O
kidneys	kidneys	O	O	O	O
from	from	O	O	O	O
these	these	O	O	O	O
rats	rats	O	O	O	O
by	by	O	O	O	O
real-time	real-time	O	O	O	O
quantitative	quantitative	O	O	O	O
TaqMan	taqman	O	O	O	O
PCR	pcr	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
the	the	O	O	O	O
amounts	amounts	O	O	O	O
of	of	O	O	O	O
proteins	proteins	O	O	O	O
by	by	O	O	O	O
Western	western	O	O	O	O
blot	blot	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
kinetics	kinetics	O	O	O	O
of	of	O	O	O	O
urinary	urinary	O	O	O	O
sodium	sodium	CHEMICALS	O	OTHERS	I
excretion	excretion	O	O	O	O
and	and	O	O	O	O
the	the	O	O	O	O
appearance	appearance	O	O	O	O
of	of	O	O	O	O
proteinuria	proteinuria	O	DISEASE	OTHERS	I
were	were	O	O	O	O
comparable	comparable	O	O	O	O
with	with	O	O	O	O
those	those	O	O	O	O
reported	reported	O	O	O	O
previously	previously	O	O	O	O
.	.	O	O	O	O

Sodium	sodium	CHEMICALS	O	OTHERS	I
retention	retention	O	O	O	O
occurred	occurred	O	O	O	O
on	on	O	O	O	O
days	days	O	O	O	O
2	2	O	O	O	O
,	,	O	O	O	O
3	3	O	O	O	O
and	and	O	O	O	O
6	6	O	O	O	O
after	after	O	O	O	O
PAN	pan	CHEMICALS	O	OTHERS	I
injection	injection	O	O	O	O
.	.	O	O	O	O

A	a	O	O	O	O
significant	significant	O	O	O	O
up-regulation	up-regulation	O	O	O	O
of	of	O	O	O	O
alphaENaC	alphaenac	O	O	O	O
and	and	O	O	O	O
betaENaC	betaenac	O	O	O	O
mRNA	mrna	O	O	O	O
abundance	abundance	O	O	O	O
on	on	O	O	O	O
days	days	O	O	O	O
1	1	O	O	O	O
and	and	O	O	O	O
2	2	O	O	O	O
preceded	preceded	O	O	O	O
sodium	sodium	CHEMICALS	O	OTHERS	I
retention	retention	O	O	O	O
on	on	O	O	O	O
days	days	O	O	O	O
2	2	O	O	O	O
and	and	O	O	O	O
3	3	O	O	O	O
.	.	O	O	O	O

Conversely	conversely	O	O	O	O
,	,	O	O	O	O
down-regulation	down-regulation	O	O	O	O
of	of	O	O	O	O
alphaENaC	alphaenac	O	O	O	O
,	,	O	O	O	O
betaENaC	betaenac	O	O	O	O
and	and	O	O	O	O
gammaENaC	gammaenac	O	O	O	O
mRNA	mrna	O	O	O	O
expression	expression	O	O	O	O
on	on	O	O	O	O
day	day	O	O	O	O
3	3	O	O	O	O
occurred	occurred	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
presence	presence	O	O	O	O
of	of	O	O	O	O
high	high	O	O	O	O
aldosterone	aldosterone	CHEMICALS	O	OTHERS	I
concentrations	concentrations	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
was	was	O	O	O	O
followed	followed	O	O	O	O
by	by	O	O	O	O
a	a	O	O	O	O
return	return	O	O	O	O
of	of	O	O	O	O
sodium	sodium	CHEMICALS	O	OTHERS	I
excretion	excretion	O	O	O	O
to	to	O	O	O	O
control	control	O	O	O	O
values	values	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
amounts	amounts	O	O	O	O
of	of	O	O	O	O
alphaENaC	alphaenac	O	O	O	O
,	,	O	O	O	O
betaENaC	betaenac	O	O	O	O
and	and	O	O	O	O
gammaENaC	gammaenac	O	O	O	O
proteins	proteins	O	O	O	O
were	were	O	O	O	O
not	not	O	O	O	O
increased	increased	O	O	O	O
during	during	O	O	O	O
PAN-induced	pan-induced	O	O	O	O
sodium	sodium	CHEMICALS	O	OTHERS	I
retention	retention	O	O	O	O
.	.	O	O	O	O

In	in	O	O	O	O
conclusion	conclusion	O	O	O	O
,	,	O	O	O	O
ENaC	enac	O	O	O	O
mRNA	mrna	O	O	O	O
expression	expression	O	O	O	O
,	,	O	O	O	O
especially	especially	O	O	O	O
alphaENaC	alphaenac	O	O	O	O
,	,	O	O	O	O
is	is	O	O	O	O
increased	increased	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
very	very	O	O	O	O
early	early	O	O	O	O
phase	phase	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
experimental	experimental	O	O	O	O
model	model	O	O	O	O
of	of	O	O	O	O
PAN-induced	pan-induced	O	O	O	O
nephrotic	nephrotic	O	DISEASE	OTHERS	I
syndrome	syndrome	O	DISEASE	OTHERS	I
in	in	O	O	O	O
rats	rats	O	O	O	O
,	,	O	O	O	O
but	but	O	O	O	O
appears	appears	O	O	O	O
to	to	O	O	O	O
escape	escape	O	O	O	O
from	from	O	O	O	O
the	the	O	O	O	O
regulation	regulation	O	O	O	O
by	by	O	O	O	O
aldosterone	aldosterone	CHEMICALS	O	OTHERS	I
after	after	O	O	O	O
day	day	O	O	O	O
3	3	O	O	O	O
.	.	O	O	O	O

